Warning letter
Torrent Pharma Inc: warning letter of Oct 28, 2019
FDA warning letter 584701 · Division of Pharmaceutical Quality Operations I
Key facts
| Reference number | 584701 |
|---|---|
| Company | Torrent Pharma Inc |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Oct 28, 2019 |
| Posted date | Nov 19, 2019 |
| Issuing office | Division of Pharmaceutical Quality Operations I |
| Product type | Drugs |
| CFR sections cited | 211.63, 201.5, 201.115, 201.128, 211.34, 211.192, 201.100(c)(2) |
| Inspection city | Levittown |
| Inspection ZIP | 19057 |
| Inspection start date | Mar 11, 2019 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: